2024
Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
Guh A, Li R, Korhonen L, Winston L, Parker E, Czaja C, Johnston H, Basiliere E, Meek J, Olson D, Fridkin S, Wilson L, Perlmutter R, Holzbauer S, D’Heilly P, Phipps E, Flores K, Dumyati G, Pierce R, Ocampo V, Wilson C, Watkins J, Gerding D, McDonald L. Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences. Open Forum Infectious Diseases 2024, 11: ofae127. PMID: 38577028, PMCID: PMC10993058, DOI: 10.1093/ofid/ofae127.Peer-Reviewed Original ResearchRecurrent Clostridioides difficile infectionClostridioides difficile infectionInitial CDINitrofurantoin useMultiple recurrent Clostridioides difficile infectionsPositive testPositive C. difficile testMultiple CDI recurrencesMultivariate logistic regression analysisPrevent further recurrenceAssociated with increased riskIntervention study designProportion of patientsTime of presentationCharacteristics of patientsLogistic regression analysisClinical decision makingCDI recurrenceChronic hemodialysisAdjunctive therapyIncreased riskMultivariate analysisStudy designPatientsClinical setting
2023
684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
Guh A, Li R, Korhonen L, Winston L, Parker E, Czaja C, Johnston H, Basiliere E, Meek J, Olson D, Fridkin S, Wilson L, Perlmutter R, Holzbauer S, D’Heilly P, Phipps E, Flores K, Dumyati G, Pierce R, Ocampo V, Wilson C, Watkins J, Gerding D, McDonald L. 684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences. Open Forum Infectious Diseases 2023, 10: ofad500.746. PMCID: PMC10677783, DOI: 10.1093/ofid/ofad500.746.Peer-Reviewed Original ResearchEmerging Infections ProgramClostridioides difficile infectionInitial Clostridioides difficile infectionInitial CDICharacteristics of patientsRecurrent CDIPositive testNitrofurantoin useRecent hospitalizationDifficile infectionPrevention's Emerging Infections ProgramRecurrent Clostridioides difficile infectionMultivariable logistic regression modelMultiple recurrent CDIPrevious positive testTime of presentationFull chart reviewGrant/research supportPrior positive testLogistic regression modelsRace/ethnicityChronic hemodialysisAdjunctive therapyChart reviewConclusions Patients
2018
482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015
Skrobarcek K, Mu Y, Ahern J, Beldavs Z, Brousseau G, Dumyati G, Farley M, Holzbauer S, Kainer M, Meek J, Perlmutter R, Phipps E, Winston L, Guh A. 482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015. Open Forum Infectious Diseases 2018, 5: s179-s179. PMCID: PMC6253049, DOI: 10.1093/ofid/ofy210.491.Peer-Reviewed Original ResearchClostridium difficile infectionEmerging Infections ProgramSocioeconomic status factorsCDC's Emerging Infections ProgramCA-CDI casesCDI risk factorsSES variablesDays of hospitalizationHealthcare-associated infectionsLow-income areasStatus factorsLow incomeMultivariable analysisCA-CDICDI surveillanceDifficile infectionRisk factorsIncidence rateInfections ProgramPositive testPrevention strategiesCensus tractsHealth disparitiesSocial determinantsHealth resources
2014
Lyme Disease Testing by Large Commercial Laboratories in the United States
Hinckley A, Connally N, Meek J, Johnson B, Kemperman M, Feldman K, White J, Mead P. Lyme Disease Testing by Large Commercial Laboratories in the United States. Clinical Infectious Diseases 2014, 59: 676-681. PMID: 24879782, PMCID: PMC4646413, DOI: 10.1093/cid/ciu397.Peer-Reviewed Original ResearchConceptsNumber of infectionsLarge commercial laboratoriesSource patientsLyme diseaseLyme disease testingFrequency of infectionTotal direct costsTwo-tiered testingCommercial laboratoriesPositive testPatientsDisease testingDiagnostic recommendationsVolume of testingLD testingInfectionDirect costsExposure historyLD testLaboratory resultsLaboratory testingUnited StatesAlternative testingTotal number